Abstract: A method for treating anxiety in a patient by orally administering to said patient a daily dose of the active ingredient, 2-pyridinyl[7-(4-pyridinyl)pyrazolo[1,5-a]-pyrimidin-3-yl]-methanone or its pharmaceutically acceptable salts especially Ocinaplonin, in two separate divided administrations, with the first portion being administered in a slow release form and the remaining portion being administered in instant release form so as to maintain the blood levels of this active ingredient at therapeutically relevant levels to keep the anti anxiety effect in the patient during the periods between administrations of this active ingredient as well as pharmaceutical compositions containing this active ingredient for administration in connection with the above method.

Abstract: N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-&agr;]-pyrimidin-7-yl}phenyl)acetamide, and use of the same as a sedative-hypnotic, anxiolytic, anticonvulsant, and skeletal muscle relaxant agent. Compositions containing N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-&agr;]-pyrimidin-7-yl}phenyl)acetamide, as well as pharmaceutically acceptable salts thereof, are also disclosed.

Abstract: N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-&agr;]-pyrimidin-7-yl}phenyl)acetamide, and use of the same as a sedative-hypnotic, anxiolytic, anticonvulsant, and skeletal muscle relaxant agent. Compositions containing N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-&agr;]-pyrimidin-7-yl}phenyl)acetamide, as well as pharmaceutically acceptable salts thereof, are also disclosed.

Abstract: The invention is a method of treatment for the relief of an addictive, compulsive disorder which comprises the administration to a human or animal suffering from such a disorder an effective amount of the compound of the formula: wherein R is hydrogen, alkyl (C1-C6); R1 is hydrogen, mono or disubstituted halogen, alkoxy (C1-C3), CF3, alkyl (C1-C6); and R2 is hydrogen, methyl or ethyl, or a pharmaceutically acceptable salt thereof.

Abstract: A method of making an electrode for use in an electrolytic process. The electrode has a core of a film-forming metal and a layer having at least a part of the outside portion of the thickness thereof of an electrolyte resistant and electrolysis product resistant material, which material contains as the material effective for carrying out electrolysis at least one oxide of at least one platinum metal taken from the group consisting of platinum, iridium, rhodium, palladium, ruthenium and osmium. The method comprises forming the platinum metal on the core and then oxidizing it, forming the oxide and then applying it to the core, or forming the oxide directly on the core, for example, by heating a solution of a salt of the metal or electrolysis.

Abstract: A coating of a protected electrocatalytic material on a dimensionally stable anode or other electrode.

Abstract: A method of making an electrode for use in an electrolytic process. The electrode has a core of a film-forming metal and a layer having at least a part of the outside portion of the thickness thereof of an electrolyte resistant and electrolysis product resistant material, which material contains as the material effective for carrying out electrolysis at least one oxide of at least one platinum metal taken from the group consisting of platinum, iridium, rhodium palladium, ruthenium and osmium. The method comprises forming the platinum metal on the core and then oxidizing it, forming the oxide and then applying it to the core, or forming the oxide directly on the core, for example, by heating a solution of a salt of the metal or electrolysis.